AVM Biotechnology President Selected to Speak at ESWI Conference in Novel and Outstanding Discoveries Track

SEATTLE, Dec. 2, 2020 /PRNewswire/ — AVM Biotechnology, a company developing a proprietary and innovative form of dexamethasone, today announced that CEO/CSO, Dr. Theresa Deisher has been selected to …
(Orginal – Story lesen…)